I N T R O D U C T I O N
Cross-resistance relationships in Mycobacterium tuberculosis were reported first with respect to streptomycin, viomycin and kanamycin. However, resistance to kanamycin in viomycin-resistant strains and that to streptomycin in kanamycin-resistant strains was only two or four times more than the resistance levels of parent strains (Steenken, Montalbine & Thurston, 1959; Tsukamura et a]. 1959 a, b ; Torii et a/. 1959; Tsukamura, I 959) . Streptomycin-dependent strains of Mycobacterium smegi?zatis and their revertants remained resistant to kanamycin (Tsukamura, I 96 I) .
The first evidence for a significant change in resistance to an agent caused by development of resistance to another agent in M . tuberculosis was with respect to viomycin and capreomycin resistances (Koseki & Okamoto, 1963 ;  Verbist & Gyselen, I 964). This relationship was extended to the relationships among viomycin, capreomycin and tuberactinomycin N resistances (Toyohara et a/. 1969; Saito, 1972; Koseki, Okamoto & Murohashi, 1973;  Tsukamura, I 974). Tsukamura (1974) isolated two types of tuberactinomycin N-resistant strains of M . tuberculosis, one resistant to low levels of tuberactinomycin N, viomycin and capreomycin and another resistant to high levels of tuberactinomycin N, viomycin, capreomycin, kanamycin and lividomycin. Although highly kanamycin-resistant strains of M . tuberculosis were resistant to capreomycin, strains only slightly resistant to kanamycin were susceptible to it. Capreomycin-resistant strains, however, were as susceptible as the parent strains to kanamycin (Tsukamura et a/. 1967; Tsukamura, 1969) . Such o ne-way ' cross-resistance relationships were observed also among lividomycin, kanamycin and/or capreomycin resistances, and among paromomycin, kanamycin and/or capreomycin (Tsukamura, Mizuno & Yamamoto, I 970 ; Tsukamura, 1972) .
Resistance patterns to aminoglucoside antibiotics are thus very complicated, and this study was undertaken in an attempt to understand more of this phenomenon.
M E T H O D S
The test strain, Mycobacterium tuberculosis H~~R V , was received from Dr S. Ata, Department of Bacteriology, Nagoya University Medical School, Nagoya, Japan, in I 947 and has since been maintained in our laboratory. The strain was purified by single-colony isolation. It was grown on Ogawa egg medium containing IOO ml of a I % (w/v) KH2P04--I "/o (w/v) sodium glutamate solution, 200 ml whole egg, 6 ml glycerol, and 6 ml of a 2 % (w/v) aqueous solution of malachite green. Eight ml of medium were poured into 170 x 17 mm tubes and made up as slants after holding at 95 "C for 60 min. Antibiotics were dissolved in distilled water and added to the medium before heating. The following antibiotics were used : streptomycin sulphate (Meiji Seika Co., Tokyo, Japan) ; viomycin sulphate (Parke, Davis & Sankyo Co., Tokyo); kanamycin sulphate (Meiji Seika Co., Tokyo) ; capreomycin sulphate (Eli Lilly Co., Basingstoke, Hampshire) ; lividomycin sulphate (Kowa Co., Tokyo) ; tuberactinomycin N sulphate (Toyo Jozo Co., Shizuoka, Japan) ; and paromomycin sulphate (Kyowa Fermentation Co., Tokyo). The concentrations of the antibiotics were 0, 10, 20, 30, 50, 100, 200, 500, 1000, and 2000 ,ug/ml. The activity of aminoglucoside antibiotics in Ogawa egg medium is about a quarter of that in Lowenstein-Jensen medium (Tsukamura & Tsukamura, I 963).
Isolation of resistant strains. The organism was cultivated on the Ogawa egg medium at 37 "C for 4 weeks; the bacterial mass was homogenized by shaking with glass beads for 10 min and then diluted with saline (0.9 %, w/v, NaCI) to give 20 to 30 mg wet wt/ml.
A series of tenfold dilutions, to IO-', was prepared in saline and from each a loopful(0-02 ml) was inoculated into media containing various concentrations of antibiotic. Tubes were stoppered with a gum cap with a pin hole and incubated at 37 "C for 4 to 8 weeks. The number of colonies was counted on media containing no agent after incubation for 4 weeks, and on media containing antibiotic after incubation for 6 weeks. Single colonies appearing after 6 to 8 weeks on media containing antibiotic were then cultivated on a medium containing no antibiotic. The resistance levels of the strains thus obtained were estimated with respect to seven antibiotics. The average rates at which resistant colonies appeared in the total viable population were calculated from ten tubes. Measurement of resistance levels. The resistance levels of the strains, measured by an 'actual count' method (Tsukamura, 1958 (Tsukamura, , 1964 Canetti et al. 1966) , are expressed as the highest concentration of an antibiotic on which an inoculum of 10 to IOO viable organisms could grow after incubation at 37 "C for 4 weeks. The bacterial suspension was prepared as described above. 1-Either 2 0 0 or 500.
LVM, lividoniycin; PM, paromycin.
R E S U L T S A N D D I S C U S S I O N
A total of 3 2 2 isolates from single colonies surviving on media containing various antibiotics were tested for resistance levels to seven antibiotics and could be classified into 1 1 phenotypes, 6R, 6R', 6R", 6R"', 4R, 3Ra, 3Rb, IR, IR-sh, IR-sm, and rR-sl ( Table I) .
The relationships between the antibiotic used for obtaining resistant mutants and the phenotype of the isolates are shown in Table 2 . The concentrations of antibiotic used were above the critical concentration, which is a point on the sigmoidal survival curve (Tsukamura, Toyama & Tsukamura, I 963).
The proportions of various mutants of the parent H37RV strain with population 10' were calculated as the product of the appearance rate of surviving colonies and the proportion of resistant strains showing the phenotype (these are shown in Table 2 ). The proportions of 6R, 6R', 6R" and 6R"' mutants showed relatively large variations, from 7-0 x 1 0 -l~ to 8.5 x I O -~, whereas the proportions of other mutants showed much less variation. The latter values, estimated by using different antibiotics, agreed well with each other. Appearance rate of 4R mutants ranged from 1 -2 x I O -~ to 3.6 x I O -~, that of 3Ra mutants from 1.0 x I O -~ to 3 -0 x IO-~, and that of 3Rb mutants from 4-6 x 10-7 to 6.1 Stability of the mutants was confirmed : the mutants retained their resistances through three transfers on media containing no antibiotic.
The most important result obtained in the present study is that resistant mutants showing the same phenotypes have been obtained using different antibiotics, it being assumed that mutants showing the same phenotype are genetically the same. For example, 3Rb mutants, which are triply resistant to tuberactinomycin N, viomycin and capreomycin, were obtained by selection with tuberactinomycin N, viomycin or capreomycin, and it is unlikely that three different mutations, each responsible for resistance to each antibiotic, would have occurred simultaneously. Similarly, 3Ra, 4R, 6R, 6R', 6R" and 6R"' mutants also are considered as have been produced by single mutation. (As 6R, 6R', 6R", and 6R"' mutants differ only slightly in their phenotypes, these may have a common main gene and a different modifier gene.) At present, complicated features of cross-resistance relationships can be seen. Thus, mutants obtained by selection with 200 pg kanamycin/ml are resistant only to kanamycin, but mutants obtained by selection with 5 0 0 p g kanamycin/ml are resistant to both kanamycin and capreomycin. On the other hand, mutants obtained by selection with a low concentration of capreomycin remain susceptible to kanamycin (Tsukamura et al. 1967; Tsukamura, 1969) . Thus there is a ' one-way ' cross-resistance relationship between kanamycin and capreomycin; until now, it has been difficult to explain this phenomenon simply.
Previously, it was supposed, a priori, that resistance to two agents, A and B, always stemmed from two different mutations. Accordingly, a 'complete ' (two-way) crossresistance phenomenon was explained by supposing that different mutations produced the same phenotype, and a ' one-way ' cross-resistance phenomenon was explained by supposing that a mutation giving resistance to A caused secondary metabolic change which resulted in resistance to B, whereas the mutation giving resistance to B caused no such secondary change. However, it appears from the present study that 'complete' (two-way) crossresistance is produced by a single gene-mutation, and the ' one-way' cross-resistance Table 3 . Classijcation of antibiotics bj7 cross-resistance relatioitships lo->) 10 R, Resistance to more than 1000 /rg/ml; r, resistance to 200 to 500 ,ug/ml (excluding the case of streptomycin); R-r, resistance to between 500 and 1000 pg/ml. relationship reveals different kinds of mutants. Reports on the ' one-way' cross-resistance relationship between kanamycin and capreomycin resulted from the observation of two types of mutants : 4R, which is resistant to kanamycin, lividomycin, paromomycin and capreomycin; and 3Rb, which is resistant to capreomycin, viomycin and tuberactinomycin N. The former (4R) was selected by kanamycin and the latter (3Rb) by capreomycin. The former has not easily been selected by capreomycin because of the difference in appearance rates of 4R and 3Rb ( I O -~, and to IO-', respectively). Both 4R and 3Rb have a chance of being selected by capreomycin, but the latter has a greater chance.
There appear to be different mechanisms of resistance, each due to single gene-mutation. There are three types of capreomycin-resistant mutants, 3Rb, 4R and 6R (6R', 6R" and 6R"'), four for kanamycin resistance ( I R, 3Ra, 4R and 6R), two for viomycin resistance (3Rb and 6R), two for tuberactinomycin N resistance (3Rb and 6R), three for lividomycin resistance (3Ra, 4R and 6R) and three for paromomycin resistance (3Ra, 4R and 6R). Among these, at least four produce cross-resistance. These are 3Ra, 3Rb, 4R and 6R (6R', 6R" and 6R"' may be further types.)
The 6R mutants were obtained by selections with kanamycin, lividomycin, paromomycin, and tuberactinomycin N but not with capreomycin even though the mutants were highly resistant to capreomycin. At present, we have no real explanation for this phenomenon.
Aminoglucoside antibiotics can be classified into three groups according to their crossresistance relationships (Table 3) . Group I would consist only of streptomycin, group I1 would contain viomycin, tuberactinomycin N and capreomycin, and group I11 contain kanamycin, lividomycin and paromomycin. The resistances to the antibiotics of group I1 are covered by the 3Rb mutants, and those to the antibiotics of group I11 by the 3Ra and 4R mutants. Though capreomycin is placed in group 11 in the Table, it is considered to be an intermediate between groups I1 and 111, as the mutants 4R cover this together with the antibiotics of group 111. Groups I1 and I11 are closely related to each other, as the resistances to these six antibiotics are covered by the 6R mutants (6R', 6R" and 6,"'). Streptomycin is clearly differentiable from these six.
